DIRS.INFO The most relevant business & tech news

☆ Stocks making the biggest moves premarket: Alphabet, Microsoft, PacWest, Snap and more
▼ + stars: | 2023-07-26 | by ( Samantha Subin | ) www.cnbc.com time to read: +4 min

Alphabet — The Google parent popped more than 6% after topping Wall Street's second-quarter earnings expectations, fueled by growth in its cloud-computing segment. Microsoft, however, did beat Wall Street's estimates, reporting earnings of $2.69 per share on $56.19 billion in revenue. Snap topped second-quarter expectations, reporting a narrower-than-expected loss of 2 cent a share on $1.07 billion in revenue. Wells Fargo also said that its board approved a previously announced dividend hike to 35 cents from 30 cents per share. The company topped earnings but fell short on revenue expectations, reporting adjusted earnings per share of 63 cents on $29.92 billion in revenue.

Persons: Ruth Porat, Refinitiv, Wells Fargo, popper, —, Sarah Min, Yun Li, Hakyung Kim, Jesse Pound Organizations: Google, Microsoft, Boeing, Texas, — Texas, Teladoc Health, Dish, Bloomberg News, Fisher, Pacific Locations: Mountain View , California, Banc, California

☆ J&J starts share exchange offer for consumer health spin-off Kenvue
▼ + stars: | 2023-07-24 | by ( ) www.reuters.com time to read: +1 min

[1/2] The Johnson & Johnson logo is displayed on a screen on the floor of the New York Stock Exchange (NYSE) in New York, U.S., May 29, 2019. REUTERS/Brendan McDermid/File PhotoJuly 24 (Reuters) - Johnson & Johnson (JNJ.N) said on Monday it had launched an exchange offer under which its stockholders can opt for shares of Kenvue <KVUE.N>, its newly listed consumer health unit. The exchange will allow J&J shareholders to exchange their shares for those of Kenvue at a 7% discount, subject to conditions. Kenvue, which debuted on the New York Stock Exchange in May, has a market capitalization of about $46 billion. ‍Goldman Sachs and J.P. Morgan Securities are serving as dealer managers for the offering, J&J said.

Persons: Johnson, Brendan McDermid, ‍ Goldman Sachs, J.P, J, Bhanvi, Shounak Dasgupta, Anil D'Silva Organizations: New York Stock Exchange, REUTERS, Johnson, Morgan Securities, Thomson Locations: New York, U.S, Kenvue, Bengaluru

☆ Wall St Week Ahead Relentless U.S. stock rally faces Fed test
▼ + stars: | 2023-07-21 | by ( David Randall | ) www.reuters.com time to read: +4 min

The S&P 500 is up nearly 19% year-to-date and closed on Thursday at 4,534.87, only about 6% below an all-time high reached in January 2022. What the Fed does and says next week will be critical," said Cliff Corso, chief investment officer at Advisors Asset Management. "Bearish investors have had to capitulate," said Liz Ann Sonders, chief investment strategist at Charles Schwab. The bank last month raised its year-end S&P 500 target to 4,500, from 4,000. However, Christopher Tsai, chief investment officer at Tsai Capital, is not worried about buying into an overvalued market.

Persons: Cliff Corso, Jonathan Golub, Tom Lee, Ed Yardeni, Liz Ann Sonders, Charles Schwab, Eric Freedman, Goldman Sachs, Sunitha Thomas, We've, Christopher Tsai, David Randall, Saqib Iqbal Ahmed, Ira Iosebashvili, Richard Chang Organizations: YORK, Federal Reserve, Fed, Asset Management, Jonathan Golub of Credit Suisse, Fundstrat Global, Yardeni Research, National Association of Active Investment, U.S, Bank Wealth Management, Consumers, Northern Trust, Tsai, MSCI Inc, Zoetis Inc, Thomson Locations: U.S, Jonathan Golub of

☆ Kenvue earnings top estimates in J&J spinoff's first quarterly report since IPO
▼ + stars: | 2023-07-20 | by ( Annika Kim Constantino | ) www.cnbc.com time to read: +4 min

Kenvue reported second-quarter revenue and adjusted earnings that topped expectations Thursday in the consumer health company's first quarterly report since it spun out from Johnson & Johnson two months ago. But J&J still owns a 90% stake in Kenvue, meaning it can generally control the direction of the spinoff's business for now. Excluding certain items, the company's adjusted earnings were 32 cents a share. The company's full-year adjusted earnings outlook is $1.26 to $1.31 per share. The company reported sales growth across its three business divisions in the second quarter.

Persons: Kenvue, Johnson, Kenvue's, Thibaut Mongon, headwinds, Mongon Organizations: Johnson, Refinitiv, Deutsche Bank Global Consumer Conference Locations: Kenvue, Canada

☆ You can now find Costco-style low prices for generic prescription drugs at Kroger in a partnership with Mark Cuban's online pharmacy
▼ + stars: | 2023-07-20 | by ( Alex Bitter | Yeji Jesse Lee | ) www.businessinsider.com time to read: +3 min

Kroger is working with Mark Cuban's Cost Plus Drugs to offer some prescriptions at its pharmacies. Cost Plus customers can now pick up their drugs at one of 2,000 Kroger pharmacies. Patients who get their drugs through Cost Plus Drugs can now pick them up at one of 2,000 stores operated by Kroger, Cost Plus tweeted on Wednesday. He started Cost Plus in 2022. Cost Plus Drugs buys drugs directly from the manufacturer and ships them to patients at a 15% markup plus pharmacy fees.

Persons: Kroger, Mark Cuban's, Mark, — Mark, It's Organizations: Service, Kroger, — Mark Cuban, Plus Drug, Dallas Mavericks NBA, Costco, Walmart, Albertsons, Intelligence Locations: Wall, Silicon, Ralph's, Cuban

☆ Johnson & Johnson investors can soon swap their shares for Kenvue stock — here's what you need to know
▼ + stars: | 2023-07-20 | by ( Annika Kim Constantino | ) www.cnbc.com time to read: +2 min

Johnson & Johnson on Thursday said its shareholders will soon be able to swap their shares for stock of Kenvue , which spun out as an independent consumer health company just two months ago. That process, also known as a split-off, will allow J&J shareholders to exchange all or a portion of their shares for Kenvue's common stock. Kenvue shares fell following the announcement Thursday, even though the company beat earnings and revenue estimates in its first quarterly report since its IPO. Previously, J&J did not disclose whether it would divest its Kenvue shares through a split-off or a spinoff. The latter would involve distributing Kenvue stock to existing J&J shareholders rather than giving them the option to exchange.

Persons: Thibaut Mongon, Paul Ruh, Johnson, J, Joseph Wolk, Wolk, J's, CNBC's, Kenvue, Goldman Sachs, JPMorgan Chase Organizations: Kenvue Inc, New York Stock Exchange, JPMorgan Locations: New York City, U.S

☆ Teladoc Health expands Microsoft tie-up to automate documentation with AI
▼ + stars: | 2023-07-18 | by ( ) www.reuters.com time to read: +1 min

July 18 (Reuters) - Teladoc Health (TDOC.N) is expanding a partnership with Microsoft (MSFT.O) to use the tech giant's artificial intelligence services to automate clinical documentation on its telehealth platform. The integration of AI services including Microsoft's OpenAI, owner of viral chatbot ChatGPT, will help ease the burden on healthcare staff during virtual exams, Teladoc said on Tuesday. The companies have been collaborating since the height of the COVID-19 pandemic in 2021, wherein Teladoc integrated its Solo virtual healthcare platform into Microsoft Teams. Teladoc will now also use Microsoft's Nuance Dragon Ambient eXperience, an AI-powered voice-enabled solution that uses the GPT4 AI service, to automatically document patient encounters, the telehealth company said. Reporting by Leroy Leo in Bengaluru; Editing by Devika SyamnathOur Standards: The Thomson Reuters Trust Principles.

Persons: Microsoft's OpenAI, Teladoc, Leroy Leo, Devika Organizations: Teladoc, Microsoft, Thomson Locations: Bengaluru

☆ Jim Cramer talks investing's uglier aspects, 'mistakes are just part of the business'
▼ + stars: | 2023-07-12 | by ( Julie Coleman | ) www.cnbc.com time to read: +1 min

CNBC's Jim Cramer on Wednesday shared with investors how the sausage really gets made. Cramer shared the more unsavory aspects of the craft, the inevitable mistakes he said most money managers won't admit to making. "Money management is an art, not a science," Cramer emphasized. "I showed the genuine disappointment today that occurred when I refused to violate my basis, an important discipline for me, and pay up for more stock," Cramer said. "Mistakes are part of the business for everybody."

Persons: CNBC's Jim Cramer, Cramer, he's, Stanley Black, Decker Organizations: CNBC, Club, CNBC's, Trust, Investing Club, Bausch Health Company

☆ A $7 billion startup wanted to build patient-friendly healthcare. Its bet on buzzy weight-loss drugs is testing that vision.
▼ + stars: | 2023-06-29 | by ( Blake Dodge | Rebecca Torrence | ) www.businessinsider.com time to read: +12 min

Patient complaints go beyond the Wegovy shortageKaitlyn's complaints echo an array of issues faced by other Ro patients seeking weight-loss drugs. The patients Insider interviewed asked to be identified by their first names to protect their privacy. In this chat log, a Ro weight-loss patient sends messages to the startup asking to cancel the program. Reitano told Insider that around 90% of Ro patients got a response within 24 hours. "Until these DTC companies generally start getting into the muck of healthcare, they're not going to have a material impact," Parker told Insider.

Persons: Ro, Zachariah Reitano, Reitano, Li Ran, Robyn Phelps, Kaitlyn, She'd, didn't, she's, couldn't, Max Kerwick, drugstores, Max, Ro's, aren't, hasn't, Florian Gaertner, it's, TJ Parker, they're, Parker Organizations: New York, Getty, Better Business Bureau, Nordisk, Better Business, CareMetx, Ro, TechCrunch Locations: Xinhua, New York, New York City

☆ Check out the 15-slide pitch deck former Bose engineers and the founders of STAT Health used to raise $5 million for a tiny in-ear wearable to prevent fainting
▼ + stars: | 2023-06-13 | by ( Leena Rao | ) www.businessinsider.com time to read: +3 min

STAT Health sells an in-ear wearable that patients can use 24/7 to track blood flow. So when Lee's elderly father began having repeated fainting sessions, Lee turned to in-ear technology to help solve the problem. His brainchild is STAT Health, an 24/7 in-ear wearable that measures blood flow to the head to better understand symptoms such as dizziness, brain fog, headaches, fainting, and fatigue that occur while standing. STAT Health's in-ear wearable. The wearable was clinically tested at Johns Hopkins University and was shown to predict fainting in users minutes before it happens.

Persons: Long, Daniel Lee, Lee, Paul Jin Organizations: Health, J2 Ventures, BonAngels Venture Partners, STAT Health, Johns Hopkins University Locations: Bose

☆ Around 400 patients were wrongly informed they might have cancer, biotech company says
▼ + stars: | 2023-06-03 | by ( Isobel Van Hagen | ) www.businessinsider.com time to read: +2 min

A biotech company said 400 people had been mistakenly informed they might have cancer. Grail Inc said the error resulted from a software issue, which has been resolved. The incident was part of a trial of an early-detection blood test called Galleri. Grail Inc, an American biotechnology company, developed an early-detection blood test called Galleri, created to identify more than 50 types of cancer before symptoms appear, per Reuters. The company, owned by gene sequencing company Illumina, said it promptly contacted patients after the incident.

Persons: —, Grail, PWNHealth, MassMutual Organizations: Inc, Service, Financial Times, British Locations: American

☆ Here are Tuesday's biggest analyst calls: Nvidia, Tesla, Ford, Wayfair, Coinbase, Disney, PayPal & more
▼ + stars: | 2023-05-30 | by ( Michael Bloom | ) www.cnbc.com time to read: +6 min

Here are Tuesday's biggest calls on Wall Street: Barclays reiterates Tesla as overweight Barclays said the stock is well positioned for more gains. "The dominant narrative ahead for Tesla is one of growth, with expectations for significant volume growth and share gains in the years ahead." Roth MKM upgrades Constellation Brands to buy from hold Roth MKM said it sees the company accelerating market share gains. "As weather warms, we expect the share gains for Modelo Especial and Corona to accelerate. Morgan Stanley upgrades Medtronic to overweight from equal weight Morgan Stanley said in its upgrade of Medtronic that it's turning an operational corner. "

☆ Nvidia's ascent continues unabated, while Citi says buy J&J
▼ + stars: | 2023-05-30 | by ( Kevin Stankiewicz | In Kevinstankiewicz | ) www.cnbc.com time to read: +6 min

Optimism for J & J, Kenvue The news : Investors should buy shares of Johnson & Johnson for its "world-leading medical technology and pharmaceutical franchises," Citigroup analysts wrote in a research note Tuesday. The firm, after a period of restriction, resumed its J & J coverage with a buy rating and $185-per-share price target. Jim said Tuesday he could see J & J jumping to around $170 per share, if plaintiffs were to approve the company's proposed settlement . J & J has long rejected plaintiffs' claims that its baby powder and other talc products caused cancer. In any case, we like Kevnue as a standalone company and will keep a close eye on its performance as we await more information from J & J management on finalizing the divestiture.

Organizations: & $

Kenvue is well-positioned for accelerated growth following its separation from parent company Johnson & Johnson, according to JPMorgan. Following its spinoff earlier in May, Kenvue is the largest pure-play consumer health company in the world. The company holds commonly-known brands such as Neutrogena, Tylenol, Aveeno and Zyrtec — amounting to 10 brands with sales greater than $400 million. "We view KVUE as uniquely positioned to benefit from consumer mega trends (self-care, aging)." JPMorgan thinks Kenvue is still trading at an attractive valuation despite jumping since its May 3 IPO, which was priced at $22 per share.

☆ A top healthcare banker names the 4 industry sectors ripe for M&A
▼ + stars: | 2023-05-10 | by ( Yeji Jesse Lee | ) www.businessinsider.com time to read: +2 min

Pearson said that she expects to see more deals in women's health, orthopedics, cardiology, and kidney care, areas that remain largely unconsolidated today. She worked with Unified Women's Healthcare in its 2020 deal with Altas Partners and Ares Management. Last year, Unified Women's Healthcare acquired digital menopause provider platform Gennev. While some companies in these sectors are making deals to obtain more digital capabilities, others are investing internally in virtual capabilities. Kidney-care-focused companies U.S. Renal Care and DaVita are also investing in their virtual capabilities, she added.

☆ Fanatics moves one step closer to IPO, hiring Meta's head of investor relations
▼ + stars: | 2023-04-27 | by ( Ian Thomas | ) www.cnbc.com time to read: +7 min

While an IPO is not on the immediate horizon, the company is taking a step in the direction of preparing for one, hiring Meta's investor relations head to further build out its engagement with current and future shareholders. Deborah Crawford, who has served as Meta 's vice president of investor relations for more than eight years, is being appointed as Fanatics' head of investor relations, a new position at the company. Prior to Meta, Crawford was head of investor relations for Netflix, where she helped initiate the streaming company's first formal investor relations function, according to Fanatics. Schiffman declined to comment on the potential timing of a Fanatics IPO but confirmed the company has a goal of going public. Fanatics has seen its valuation and investor roster drastically expand in recent years, which has also helped to fuel IPO chatter.

☆ Here are Thursday's biggest analyst calls: Tesla, Amazon, GE, Home Depot, Elanco, SeaWorld & more
▼ + stars: | 2023-04-20 | by ( Michael Bloom | ) www.cnbc.com time to read: +7 min

Goldman Sachs reiterates Tesla as buy Goldman says Tesla's earnings report on Wednesday was a "negative" but that it's standing by the stock. Bank of America reiterates Amazon as buy Bank of America says it's standing by Amazon heading into earnings next week. Bank of America upgrades WestRock to buy from neutral Bank of America said in its upgrade of the packaging solutions company that it sees "transformation benefits." Bank of America downgrades NetApp to underperform from neutral Bank of America said in its downgrade of the hybrid cloud data services company that it sees weaker demand. Morgan Stanley initiates SeaWorld as overweight Morgan Stanley said in its initiation of SeaWorld that it sees an attractive risk/reward.

☆ The creepy secret behind online therapy
▼ + stars: | 2023-04-20 | by ( Tanmoy Goswami | ) www.businessinsider.com time to read: +16 min

Crisis Text Line, now in its 10th year of operations, uses artificial intelligence to respond to people experiencing emotional abuse, self-harm, and suicidal thoughts. 'The vast majority of mental-health apps are exceptionally creepy'BetterHelp, a poster child of online therapy founded in 2013, calls itself "the world's largest therapy platform" and says it has over 2 million users. One of the first popular mental-health apps, PTSD Coach, was launched by the US Department of Veteran Affairs in 2011. But for mental-health companies these practices can undermine the very foundations of mental-health care: dignity, trust, and psychological safety. As Crisis Text Line wrote on its website extolling its deal with Loris: "Why sell T-shirts when you can sell what your organization does best?"

☆ Torch Capital's founder has some advice for startup founders: Down rounds aren't such a bad thing right now. Here's why.
▼ + stars: | 2023-04-17 | by ( April Joyner | ) www.businessinsider.com time to read: +3 min

Jonathan Keidan founded VC firm Torch Capital, which backed Ro and recently raised $200 million. Good founders will opt for down rounds over deal terms that could come back to bite, he says. As venture capital funding plummets and investors tighten their purse strings, Jonathan Keidan has a word of advice to startup founders: It's OK to take a down round. Most of the founders Torch has backed, Keidan said, are still steering clear of the relatively sluggish market. "You can roll up your sleeves and really help them, which has been critical in this environment," Keidan told Insider.

☆ Israeli turmoil alarms business leaders: There's 'fear over what happens next'
▼ + stars: | 2023-03-29 | by ( Jason Gewirtz | ) www.cnbc.com time to read: +5 min

The uncertainty in Israel's political situation extends deep into the business sector. This month, ratings service Fitch warned that the courts controversy "could weaken Israel's credit profile." Weingarten's big fear is an irreparable divide in Israel, a country where a great degree of unity was once seen as a given. Such a drop would make the prime minister push his right-wing coalition partners into a deal that's more aligned with the country's citizens at large. Women dressed as handmaidens from "The Handmaid's Tale" attend a demonstration after Israeli Prime Minister Benjamin Netanyahu dismissed the defense minister and his nationalist coalition government presses on with its judicial overhaul, in Jerusalem on March 27, 2023.

☆ Venture Capital Investors Are Trying to Take Over Pandemic Response
▼ + stars: | 2023-03-12 | by ( Adam Rogers | ) www.businessinsider.com time to read: +19 min

Private capital has been eyeing public health for years. Several founders and investors told me that the failure of Kleiner's fund made Silicon Valley wary of investing in pandemic preparedness. Venture investors love that kind of thing. Public health and private industryWhen COVID hit, Charity Dean was the assistant director of the California Department of Public Health. In the end, almost every pandemic-related product created by Silicon Valley will ultimately require the government as a primary customer.

☆ How to invest in new AI technologies like ChatGPT, DALL-E, and more: Wall Street analysts weigh in
▼ + stars: | 2023-03-09 | by ( Business Insider | ) www.businessinsider.com time to read: +4 min

Wall Street is taking note, as analysts pick their favorite AI stocks to buy now for profits later. Students are using ChatGPT to write papers, job seekers are using it to write cover letters, and some employees are even surreptitiously using the AI chatbot to do their jobs for them. ChatGPT is just the tip of the spear, as AI seems poised to upend industries around the globe. Bank of America analysts predict that the AI industry will be worth $900 billion by 2026. Luckily, Insider has been collecting research notes, interviewing analysts, and investigating which stocks will enjoy the biggest returns from the explosive growth of AI.

☆ WeightWatchers Moves Into the Ozempic Market With Telehealth Deal
▼ + stars: | 2023-03-07 | by ( Andrea Petersen | ) www.wsj.com time to read: 1 min

WW, known for food-tracking and lifestyle changes, is moving to also offer customers a medical weight-loss approach. WW International Inc., known as WeightWatchers, is buying digital health company Sequence, marking the diet company’s move into the hot market for diabetes and obesity drugs including Ozempic and Wegovy. Sequence is a subscription service that offers telehealth visits with doctors who can prescribe the drugs. WeightWatchers, which has long promised to help customers lose weight through food-tracking and lifestyle changes, is moving to also offer customers a medical weight-loss approach.

☆ Here are Tuesday's biggest analyst calls: Apple, Amazon, Arista, Costco, Joby, Netflix & more
▼ + stars: | 2023-03-07 | by ( Michael Bloom | ) www.cnbc.com time to read: +6 min

Here are Tuesday's biggest calls on Wall Street: Northcoast upgrades Costco to buy from hold Northcoast said it sees more upside for the wholesale retailer. " Goldman Sachs initiates Arista Networks and Juniper as buy Goldman initiated several networking equipment stocks, noting they are attractively valued. Deutsche Bank downgrades Joby to sell from hold Deutsche said it sees too many risks for the aviation company. Morgan Stanley reiterates Walmart as overweight Morgan Stanley said its standing by shares of Walmart as the retail giant continues to sign up new members for its Walmart+. Loop reiterates Netflix as hold Loop said its survey checks show that password sharing charging is increasing revenue for Netflix.

☆ FTC bans online mental health company BetterHelp from sharing user data for targeted ads, as federal crackdowns on info misuse intensify
▼ + stars: | 2023-03-02 | by ( Aaron Mcdade | ) www.businessinsider.com time to read: +4 min

The FTC announced a settlement with BetterHelp over allegations of sharing user data with third parties. BetterHelp will be banned from sharing the data with outside parties for advertising, and pay $7.8 million in partial refunds. Users who signed up from August 2017 through 2020 may have had their data improperly shared, per the FTC. He continued: "Instead, BetterHelp betrayed consumers' most personal health information for profit. The company was similarly banned from sharing the health information of its users with advertisers, and agreed to pay a $1.5 million fine.

Search resuls for: "Health Company"

25 mentions found